LeadIQ logo
Learn more at LeadIQ.com

Insights

Precision Genetic Medicines Verve Therapeutics specializes in developing precision genetic medicines for coronary heart disease, offering potential sales opportunities for healthcare providers and institutions looking to advance personalized treatments.

Strategic Investment Interest Recent investments from Algert Global LLC and Sierra Summit Advisors LLC indicate growing strategic interest in Verve Therapeutics, presenting opportunities for partnerships or collaborations with other investment firms or biotech companies.

Legal Cases Impact Ongoing legal issues related to class action lawsuits against Verve Therapeutics present an opportunity for legal services providers or consultants specializing in securities fraud to offer support or guidance to the company.

Board Expansion The appointment of Nia Tatsis and Jodie Morrison to Verve Therapeutics' board signals growth and potential partnerships within the biotech industry, creating opportunities for networking or collaborations with industry experts.

Financial Backing Potential With a solid revenue base and significant funding of $144 million, Verve Therapeutics represents a potential sales opportunity for financial institutions or investment firms interested in providing financial backing or support for the company's growth initiatives.

Verve Therapeutics Tech Stack

Verve Therapeutics uses 8 technology products and services including Varnish, Fastly, Adobe Fonts, and more. Explore Verve Therapeutics's tech stack below.

  • Varnish
    Caching
  • Fastly
    Content Delivery Network
  • Adobe Fonts
    Font Scripts
  • Cisco
    Network Hardware
  • .NET
    Programming Languages
  • C#
    Programming Languages
  • Smartsheet
    Project Management
  • X-XSS-Protection
    Security

Media & News

Verve Therapeutics's Email Address Formats

Verve Therapeutics uses at least 1 format(s):
Verve Therapeutics Email FormatsExamplePercentage
FLast@vervetx.comJDoe@vervetx.com
97%
Last@vervetx.comDoe@vervetx.com
2%
FirLast@vervetx.comJohDoe@vervetx.com
1%

Frequently Asked Questions

Where is Verve Therapeutics's headquarters located?

Minus sign iconPlus sign iconVerve Therapeutics's main headquarters is located at 201 Brookline Ave Suite 601 Boston, Massachusetts 02215 US. The company has employees across 5 continents, including North AmericaEuropeAfrica.

What is Verve Therapeutics's stock symbol?

Minus sign iconPlus sign iconVerve Therapeutics is a publicly traded company; the company's stock symbol is VERV.

What is Verve Therapeutics's official website and social media links?

Minus sign iconPlus sign iconVerve Therapeutics's official website is vervetx.com and has social profiles on LinkedIn.

How much revenue does Verve Therapeutics generate?

Minus sign iconPlus sign icon As of November 2024, Verve Therapeutics's annual revenue reached $75M.

What is Verve Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconVerve Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Verve Therapeutics have currently?

Minus sign iconPlus sign iconAs of November 2024, Verve Therapeutics has approximately 295 employees across 5 continents, including North AmericaEuropeAfrica. Key team members include Chief Executive Officer, Founder: S. S. K.Chief Scientific Officer: T. L.Chief Technical Officer: J. P.. Explore Verve Therapeutics's employee directory with LeadIQ.

What industry does Verve Therapeutics belong to?

Minus sign iconPlus sign iconVerve Therapeutics operates in the Biotechnology Research industry.

What technology does Verve Therapeutics use?

Minus sign iconPlus sign iconVerve Therapeutics's tech stack includes VarnishFastlyAdobe FontsCisco.NETC#SmartsheetX-XSS-Protection.

What is Verve Therapeutics's email format?

Minus sign iconPlus sign iconVerve Therapeutics's email format typically follows the pattern of . Find more Verve Therapeutics email formats with LeadIQ.

How much funding has Verve Therapeutics raised to date?

Minus sign iconPlus sign icon As of November 2024, Verve Therapeutics has raised $144M in funding. The last funding round occurred on Nov 28, 2023 for $144M.

When was Verve Therapeutics founded?

Minus sign iconPlus sign iconVerve Therapeutics was founded in 2018.
Verve Therapeutics

Verve Therapeutics

Biotechnology ResearchMassachusetts, United States201-500 Employees

Verve Therapeutics is a clinical-stage biotechnology company created with a singular focus: to protect the world from heart disease. Founded by world-leading experts in cardiovascular medicine, human genetics and gene editing, the company aims to develop transformative, once-and-done therapies for coronary heart disease. Verve’s gene editing medicines are designed to safely edit the genome of adults and mimic naturally occurring gene variants to permanently lower LDL cholesterol and triglyceride levels. The company is advancing a pipeline of precision genetic medicines, led by VERVE-101, which is being developed initially for heterozygous familial hypercholesterolemia, a potentially fatal genetic heart disease. In 2023, Verve was recognized as a "Best Places to Work" by the Boston Globe. Verve is headquartered in Boston, Massachusetts.

Section iconCompany Overview

Headquarters
201 Brookline Ave Suite 601 Boston, Massachusetts 02215 US
Website
vervetx.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
VERV
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $144M

    Verve Therapeutics has raised a total of $144M of funding over 5 rounds. Their latest funding round was raised on Nov 28, 2023 in the amount of $144M.

  • $50M$100M

    Verve Therapeutics's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $144M

    Verve Therapeutics has raised a total of $144M of funding over 5 rounds. Their latest funding round was raised on Nov 28, 2023 in the amount of $144M.

  • $50M$100M

    Verve Therapeutics's revenue is in the range of $50M$100M

Company Leadership

  • Stylized image of a person
    S. S. K.
    Chief Executive Officer, Founder
    Phone icon
    Mobile Phone
  • Stylized image of a person
    T. L.
    Chief Scientific Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. P.
    Chief Technical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    F. T. F.
    Chief Medical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. N.
    Chief Administrative Officer
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    J. P.
    Chief Technical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    F. T. F.
    Chief Medical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. T.
    Founder And Board Member
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. A.
    Chairman Of The Board
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. N.
    Chief Administrative Officer
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.